David Willner

Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates

Pamela A. Trail, David Willner, Shirley J. Lasch et al. · Science · 1993 · 550 citations

Tumor Biology, Cancer Immunosurveillance, Lewis Y +13

Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates:  Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity

Gene M. Dubowchik, Raymond A. Firestone, Linda Padilla et al. · Bioconjugate Chemistry · 2002 · 535 citations

Immunocytochemical Technique, Glycobiology, Immunology +20

(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin

David Willner, Pamela A. Trail, Sandra J. Hofstead et al. · Bioconjugate Chemistry · 1993 · 222 citations

Pharmaceutical Science, Bioorganic Chemistry, Immunology +17

New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity

Takushi Kaneko, David Willner, Ivo Monković et al. · Bioconjugate Chemistry · 1991 · 162 citations

Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers:  Inhibition of Aggregation by Methoxytriethyleneglycol Chains

Dalton King, Gene M. Dubowchik, Harold Mastalerz et al. · Journal of Medicinal Chemistry · 2002 · 134 citations

Peptide Engineering, Immunology, Molecular Biology +21